Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinfeng Capsule vs Glucosamine for Knee Osteoarthritis
NCT02167516Completed
- Start
- Oct 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Xinfeng capsule in knee osteoarthritis (OA) (2 arms). Primary endpoint: Western Ontario and McMaster Osteoarthritis Index at 4 weeks. Started Oct 2014; status: completed.
02
Drugs
Xinfeng capsule
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02167516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02167516.